SG
GRI

StoneX Group’s GRI Bio GRI Stock Holding History

StoneX Group’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-580
Closed -$4.01K – 1054
2025
Q4 		$4.01K Buy
+580
New +$25K ﹤0.01% 1044

Other funds holding GRI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

StoneX Group's GRI Position: Q1 2026 in Review

StoneX Group sold out of GRI Bio (GRI) in Q1 2026, closing a stake of 580 shares — an estimated $4.01K sold.

StoneX Group first reported a position in GRI in Q4 2025 and held it in 1 quarter. The position peaked at $4.01K in Q4 2025. 6 funds tracked by Wall St. Rank hold GRI as of Q1 2026.

  • StoneX Group reported no remaining GRI Bio position as of Q1 2026 after selling out during the quarter.
  • StoneX Group sold 580 GRI Bio shares in Q1 2026, an estimated $4.01K.
  • StoneX Group first reported a position in GRI Bio in Q4 2025 and held it in 1 quarter.
  • StoneX Group's GRI Bio position peaked at $4.01K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held GRI Bio as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.